The COVID-19 pandemic led to an unprecedented crisis, and early on, it has been shown
that diabetes is an important risk factor for complications and mortality in infected patients, as …

Diabetes is one of the most common comorbidities in hospitalized patients with coronavirus
disease 2019 (COVID-19). Inpatient hyperglycemia during this pandemic has been …

OBJECTIVE Diabetes and the outpatient diabetes treatment regimen have been identified
as risk factors for poor outcomes in patients with sepsis. However, little is known about the …

Abstract Background & Aims At-admission hyperglycemia have been associated with poorer
outcome during critical illnesses. At-admission hyperglycemia in previously unknown …

Hyperglycemia is commonly associated with adverse outcomes especially in patients
requiring intensive care unit stay. Data from the corona virus disease 2019 (COVID-19) …

Background: Given the mortality risk in COVID-19 patients, it is necessary to estimate the
impact of glycemic control on mortality rates among inpatients by designing and …

In the latter part of 2019, a cluster of unexplained pneumonia cases were reported in
Wuhan, China. In less than a year, SARS-CoV-2 has infected over 27 million people and …

Introduction The role of glycemic control, both prior and during hospitalization, on mortality
from COVID-19 in diabetic patients is debated. Furthermore, it is not clear whether …

OBJECTIVE Diabetes and hyperglycemia are important risk factors for poor outcomes in
hospitalized patients with coronavirus disease 2019 (COVID-19). We hypothesized that …

Diabetes mellitus (DM) has emerged as a major risk factor for COVID-19 severity and SARS-
CoV-2 infection can worsen glycemic control and may precipitate new-onset diabetes. At …